Mesa Laboratories, Inc. (MLAB) operates as a global enterprise focused on the creation, production, and distribution of essential life science tools, quality assurance products, and specialized services. Its market reach extends across the United States, Europe, the Asia Pacific region, and other international territories. The company's operations are organized into four distinct segments: 1. Sterilization and Disinfection Control: This division manufactures and supplies biological, chemical, and cleaning indicators designed to verify the effectiveness of sterilization and disinfection protocols. These products are vital for industries such as hospitals, dental practices, medical device manufacturing, and pharmaceuticals. Additionally, it offers specialized testing and laboratory services, primarily catering to the dental sector. 2. Biopharmaceutical Development: This segment is dedicated to developing, producing, and marketing automated solutions for protein analysis, including immunoassays, and comprehensive peptide synthesis technologies. Its portfolio encompasses analysis equipment, CDs, kits, and buffers for protein analysis, alongside peptide synthesizers that automate the chemical creation of peptides. These synthesized peptides are utilized in the development of therapeutic agents, biomaterials, cosmetic products, and general scientific research. 3. Calibration Solutions: This division designs, manufactures, and commercializes quality control and calibration instruments. These products are crucial for accurately measuring and calibrating parameters such as temperature, pressure, pH, and humidity, ensuring health and safety standards. Their applications span hospitals, medical device and pharmaceutical manufacturing facilities, and various laboratory and healthcare environments. Key offerings include continuous monitoring systems, dialysate meters and their consumables, data logging devices, gas flow calibration and air sampling equipment, and torque testing systems. 4. Clinical Genomics: This segment innovates, produces, and provides advanced genetic analysis tools. A prominent offering is the MassARRAY system, complemented by essential consumables like chips, panels, and chemical reagent solutions. These tools enable clinical laboratories to perform genomic testing across several therapeutic areas, including newborn screening, pharmacogenomics, and oncology. Mesa Laboratories, Inc. was established in 1982 and is headquartered in Lakewood, Colorado.
fool.comWhy Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Todayfool.comMay 27
globenewswire.comMesa Labs Announces Fourth Quarter and Fiscal Year 2026 Resultsglobenewswire.comMay 27
globenewswire.comMesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026globenewswire.comMay 5
globenewswire.comMESA LABS DECLARES QUARTERLY DIVIDENDglobenewswire.comApr 2
defenseworld.netMesa Laboratories (NASDAQ:MLAB) Stock Price Passes Above 200-Day Moving Average – Here’s What Happeneddefenseworld.netMar 25